Helmet Ventilation in Acute Hypercapnic Respiratory Failure
- Conditions
- Hypercapnic Respiratory FailureChronic Obstructive Pulmonary Disease
- Interventions
- Device: Helmet (Starmed)Device: Total Face mask (Respironics)
- Registration Number
- NCT01645358
- Brief Summary
Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory failure, it is largely employed as a "rotating" strategy when the facial mask is poorly tolerated.
In a multicenter randomized controlled trial, the investigators will compare the clinical efficacy of a new helmet designed to specifically improve the performance in chronic obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- pH < 7,35 and PaCO2 > 45 mmHg
- respiratory rate > 20 b/min
- hypoxic respiratory failure
- coma
- inability to stand NIV
- lack of informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Helmet to deliver NIV Helmet (Starmed) - Total Face to deliver NIV Total Face mask (Respironics) -
- Primary Outcome Measures
Name Time Method Arterial Blood gases at 1 hour after the start of NIV
- Secondary Outcome Measures
Name Time Method Arterial Blood Gases Once a day at 8 am until discharge
Trial Locations
- Locations (2)
Sant'Orsola malpighi Hospital
🇮🇹Bologna, Italy
Sant'Orsola Malpighi
🇮🇹Bologna, Italy